Fiedler Wolfgang, Hoppe Constance, Schimmel Bettina, Koscielny Sven, Dahse Regine, Bereczki Zsuzsa, Claussen Uwe, Ernst Günther, von Eggeling Ferdinand
Institute of Human Genetics and Anthropology, Friedrich-Schiller-University, D-07740 Jena, Germany.
Int J Mol Med. 2002 Apr;9(4):417-23.
Head and neck cancer is a frequent malignancy with a complex, and up to now not clear etiology. The reactivation of telomerase activity and losses or gains of specific chromosomal regions, which point to deletions of tumor suppressor genes or amplification of oncogenes are supposed to be the molecular processes during the development and progression of head and neck cancer. Therefore, we analyzed telomerase activity and microsatellite markers using a genome wide panel of 28 microsatellite markers in 38 head and neck squamous-cell carcinomas (HNSCC). Our microsatellite marker set included distinct chromosomal areas that all likely harbor genes contributing to the carcinogenesis of HNSCC. DNA or protein lysates were obtained from primary tumors and compared to peripheral lymphocytes or corresponding normal tissue. At least one genomic alteration [loss of heterozygosity (LOH), or microsatellite instability (MSI)] was found in 31 of the 38 cases (82%). Most frequently we detected an LOH in the chromosomal region 9p12-21 where at least the tumor suppressor genes (TSG) p16INK4A, p14ARF and p15INKB are localized. The comparison between grade two and grade three tumors showed a highly changed frequency of LOH in the chromosomal region 7q31, where a putative TSG is predicted. Telomerase activity was present in 31/37 (83.8%) tumor samples independent of the histopathological staging and grading of the tumors. These molecular characterizations of HNSCC may be a further hint for the involvement of additional, so far unknown, TSGs in the tumor progression and will elucidate the regulation of telomerase.
头颈癌是一种常见的恶性肿瘤,其病因复杂,至今尚不明确。端粒酶活性的重新激活以及特定染色体区域的缺失或增加,这表明肿瘤抑制基因的缺失或癌基因的扩增,被认为是头颈癌发生和发展过程中的分子过程。因此,我们使用包含28个微卫星标记的全基因组面板,对38例头颈部鳞状细胞癌(HNSCC)进行了端粒酶活性和微卫星标记分析。我们的微卫星标记集包括不同的染色体区域,所有这些区域可能都含有对头颈癌发生有贡献的基因。从原发性肿瘤中获取DNA或蛋白质裂解物,并与外周淋巴细胞或相应的正常组织进行比较。在38例病例中的31例(82%)中发现了至少一种基因组改变[杂合性缺失(LOH)或微卫星不稳定性(MSI)]。我们最常检测到9p12 - 21染色体区域的LOH,该区域至少定位有肿瘤抑制基因(TSG)p16INK4A、p14ARF和p15INKB。二级和三级肿瘤之间的比较显示,7q31染色体区域的LOH频率变化很大,该区域预测有一个假定的TSG。31/37(83.8%)的肿瘤样本中存在端粒酶活性,与肿瘤的组织病理学分期和分级无关。HNSCC的这些分子特征可能进一步提示在肿瘤进展中还有其他目前未知的TSG参与其中,并将阐明端粒酶的调控机制。